Limited impact of column chemistry and length on proteome coverage under high-speed DIA
Ontology highlight
ABSTRACT: The evolution of mass spectrometry-based proteomics has been driven by continuous advances in instrumentation, sample preparation, and data acquisition strategies. While chromatographic separation has historically been considered a critical bottleneck in achieving comprehensive proteome coverage, recent developments in ultra-fast mass spectrometry acquisition fundamentally challenge this paradigm. We investigated whether traditional chromatographic optimization principles established during the early era of proteomics remain essential in contemporary workflows. Using five distinct stationary phases, C18 chemistries, C8, and Phenyl-Hexyl, across eight column lengths (40-140 mm), we evaluated proteome identification performance using state-of-the-art data-independent acquisition on the Orbitrap Astral mass spectrometer with HeLa tryptic digests. Despite substantial chromatographic differences in selectivity and peak characteristics that would have profoundly influenced analytical outcomes in earlier instrumentation generations, we observed remarkably convergent proteome coverage metrics. All C18 and C8 phases consistently achieved over 150,000 precursor and approximately 9,000 protein group identifications, regardless of column length variations. While distinct selectivity fingerprints persisted across chemistries, these chromatographic differences did not translate into meaningful variations in bulk identification depth under high-speed acquisition conditions exceeding 200 Hz. From these findings we conclude that the analytical bottleneck has fundamentally shifted from chromatographic resolution to mass spectrometric sampling efficiency, where comprehensive peptide identification is now achieved through advanced spectral deconvolution rather than physical separation alone. This paradigmatic shift suggests that method development priorities in modern proteomics should evolve beyond traditional separation optimization to emphasize operational robustness, analytical throughput, and systematic reproducibility for routine applications.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Hela Cell
SUBMITTER:
Mario Oroshi
LAB HEAD: Dr. Johannes Bruno Müller-Reif
PROVIDER: PXD067710 | Pride | 2026-06-22
REPOSITORIES: Pride
ACCESS DATA